These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 29159953)

  • 1. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
    Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
    Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
    Sessa M; Mascolo A; Rasmussen DB; Kragholm K; Jensen MT; Sportiello L; Rafaniello C; Tari GM; Pagliaro C; Andersen M; Rossi F; Capuano A
    Sci Rep; 2019 Aug; 9(1):11465. PubMed ID: 31391573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metoprolol Versus Carvedilol in Patients With Heart Failure, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, and Renal Failure.
    Sessa M; Rasmussen DB; Jensen MT; Kragholm K; Torp-Pedersen C; Andersen M
    Am J Cardiol; 2020 Apr; 125(7):1069-1076. PubMed ID: 32000982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.
    Su VY; Chang YS; Hu YW; Hung MH; Ou SM; Lee FY; Chou KT; Yang KY; Perng DW; Chen TJ; Liu CJ
    Medicine (Baltimore); 2016 Feb; 95(5):e2427. PubMed ID: 26844454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study.
    Sessa M; Mascolo A; Scavone C; Perone I; Di Giorgio A; Tari M; Fucile A; De Angelis A; Rasmussen DB; Jensen MT; Kragholm K; Rossi F; Capuano A; Sportiello L
    Front Pharmacol; 2018; 9():1212. PubMed ID: 30459608
    [No Abstract]   [Full Text] [Related]  

  • 8. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
    Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study.
    Bølling R; Scheller NM; Køber L; Poulsen HE; Gislason GH; Torp-Pedersen C
    Eur J Heart Fail; 2014 Jun; 16(6):678-84. PubMed ID: 24706485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
    Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L;
    Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Philbert BT; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Sep; 20(FI2):f217-f224. PubMed ID: 29684191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Seo GW; Kim DK; Kim KH; Seol SH; Jin HY; Yang TH; Ahn Y; Jeong MH; Song PS; Kim DI;
    Am J Cardiol; 2015 Nov; 116(10):1502-8. PubMed ID: 26520013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
    DiNicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH
    Am J Cardiol; 2013 Mar; 111(5):765-9. PubMed ID: 23290925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.
    Taborsky M; Aiglova R; Lazarova M; Pavlu L; Danek J; Precek J; Schee A; Gloger V; Vicha M; Skala T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Nov; 165(4):402-407. PubMed ID: 33325457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
    Zhou H; Sim JJ; Shi J; Shaw SF; Lee MS; Neyer JR; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ
    Am J Kidney Dis; 2021 May; 77(5):704-712. PubMed ID: 33010357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Lee SE; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
    Korean J Intern Med; 2019 Sep; 34(5):1030-1039. PubMed ID: 30317846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.